Real-World Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2018.04.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Real‐World Adherence in Patients With Metastatic Colorectal Cancer Treated With Trifluridine Plus Tipiracil or Regorafenib

Oncologist
Cancer ResearchMedicineOncology
2019English

Duration of Previous Treatment as a Prognostic Factor in Metastatic Colorectal Cancer Treated With Trifluridine/Tipiracil

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Real-World Two-Year Treatment Patterns Among Patients With Psoriatic Arthritis Treated With Injectable Biologic Therapies

Current Medical Research and Opinion
Medicine
2020English

Cost Effectiveness of Trifluridine/Tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

A Retrospective Study of Trifluridine/Tipiracil in Pretreated Metastatic Colorectal Cancer Patients in Clinical Practice

Colorectal Cancer
OncologyGastroenterology
2018English

Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Real-World Treatment Patterns Among Patients With Advanced Gastric Cancer in Russia: A Chart Review Study

Journal of Drug Assessment
2019English

Emerging Combination Therapies for Metastatic Colorectal Cancer &Ndash; Impact of Trifluridine/Tipiracil

Cancer Management and Research
Oncology
2017English

Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy